MTOR and non-small cell lung carcinoma: After treatment of NSCLC cells, the phosphorylation of mTOR upstream kinase Akt, mTOR, and its downstream target ribosomal S6 kinase 1, whose activation dictates various physiological and pathological processes such as growth, cell proliferation, homeostasis, survival, and metastasis, was significantly reduced [206].